Financials & SEC Filings | Xeris Biopharma Holdings, Inc.

Proxy Statements

Filing date	Description	Form	View
Feb 01, 2019	Statement of changes in beneficial ownership of securities	4	View HTML 0000899243-19-002332.pdf 0000899243-19-002332.rtf 0000899243-19-002332.xls
Feb 01, 2019	Statement of changes in beneficial ownership of securities	4	View HTML 0000899243-19-002331.pdf 0000899243-19-002331.rtf 0000899243-19-002331.xls
Feb 07, 2019	Statement of changes in beneficial ownership of securities	4	View HTML 0001193805-19-000117.pdf 0001193805-19-000117.rtf 0001193805-19-000117.xls
Feb 08, 2019	Securities offered to employees pursuant to employee benefit plans	S-8	View HTML 0001193125-19-032355.pdf 0001193125-19-032355.rtf 0001193125-19-032355.xls
Feb 08, 2019	UPLOAD	UPLOAD	View HTML 0000000000-19-001649.pdf 0000000000-19-001649.rtf
Feb 11, 2019	Registration statement for face-amount certificate companies	S-1	View HTML 0001193125-19-033935.pdf 0001193125-19-033935.rtf 0001193125-19-033935.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Feb 11, 2019	CORRESP	CORRESP	View HTML 0001193125-19-034089.pdf 0001193125-19-034089.rtf 0001193125-19-034089.xls
Feb 11, 2019	CORRESP	CORRESP	View HTML 0001193125-19-034084.pdf 0001193125-19-034084.rtf 0001193125-19-034084.xls
Feb 12, 2019	An amendment to the SC 13G filing	SC 13G/A	View HTML 0001193805-19-000204.pdf 0001193805-19-000204.rtf 0001193805-19-000204.xls
Feb 12, 2019	Statement of changes in beneficial ownership of securities	4	View HTML 0001193805-19-000209.pdf 0001193805-19-000209.rtf 0001193805-19-000209.xls

Data provided by Kaleidoscope.